🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety of dasatinib (BMS-354825) in subjects with Imatinib re...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT01030718
Treatments Being Tested
This is a single center, four-treatment, four period, crossover study to ev...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00422825
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Duke Cancer Institute
Start Date
2005-05
Trial ID
NCT00354913
Treatments Being Tested
Phase I/II trial to study the effectiveness of combining STI571 and chemoth...
Status
Completed
Location
University of California at Los Angeles (UCLA )
Start Date
2001-05
Trial ID
NCT00015834
Treatments Being Tested
The study is a multi-center, multi-national, open label, single arm Phase I...
Status
Completed
Location
U.Z. Leuven - Campus Gasthuisberg (147)
Start Date
2017-02-02
Trial ID
NCT02216578
Treatments Being Tested
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Completed
Location
Universita Degli Studi di Bari
Start Date
2007-03
Trial ID
NCT00466726
Treatments Being Tested
This is a randomised, open-label, multicenter, phase III study for adult de...
Status
Active Not Recruiting
Location
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia
Start Date
2021-09-08
Trial ID
NCT04722848
Treatments Being Tested
The primary purpose is to monitor the safety and tolerability and effective...
Status
Terminated
Location
Chong Hua Hospital
Start Date
2010-02
Trial ID
NCT01073644
Treatments Being Tested
This phase II trial studies how well binimetinib and imatinib work in treat...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2021-03-03
Trial ID
NCT04598009
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Center
Start Date
2003-07
Trial ID
NCT00268229
Treatments Being Tested